Recent developments and future perspectives in aging and macrophage immunometabolism
AIMS Molecular Science · 2021 · 8 (3) · 193-201
DOI: 10.3934/molsci.2021015 ↗Kurz gefasst
Fachartikel in der Zeitschrift AIMS Molecular Science, 2021. Verfasst von Brandt D. Pence. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 58 Literaturangaben.
Abstract (Originalsprache)
Aging is the strongest contributor to the development and severity of many chronic and infectious diseases, primarily through age-related increases in low-grade inflammation (inflammaging) and decreases in immune function (immunosenescence). Metabolic reprogramming in immune cells is a significant contributor to functional and phenotypic changes in these cells, but little is known about the direct effect of aging on immunometabolism. This review highlights several recent advances in this field, focusing on mitochondrial dysfunction, NAD+ metabolism, and therapeutic reprogramming in aged monocytes and macrophages. Perspectives on opportunities for future research in this area are also provided. Targeting immunometabolism is a promising strategy for designing therapeutics for a wide variety of age-related diseases.
Zitieren
APA
Pence, B. D. (2021). Recent developments and future perspectives in aging and macrophage immunometabolism. AIMS Molecular Science, 8(3), 193-201. https://doi.org/10.3934/molsci.2021015
Vancouver
Pence BD. Recent developments and future perspectives in aging and macrophage immunometabolism. AIMS Molecular Science. 2021;8(3):193-201. doi:10.3934/molsci.2021015
BibTeX
@article{Pence2021,
author = {Pence, Brandt D.},
title = {Recent developments and future perspectives in aging and macrophage immunometabolism},
journal = {AIMS Molecular Science},
year = {2021},
volume = {8},
number = {3},
pages = {193--201},
doi = {10.3934/molsci.2021015}
}
EUVIMED